Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Predicted Market Size Of The Multivalent Vaccines Industry By 2029?

The market for multivalent vaccines has seen significant growth in the past few years. This market is set to expand from $8.37 billion in 2024 to $9.12 billion in 2025, equating to a compound annual growth rate (CAGR) of 8.9%. This considerable growth in the earlier period is due to factors such as increased public understanding about the importance of vaccination, greater government support, a rise in the demand for pediatric multivalent vaccines, an uptick in funding for vaccine-related research, and a general surge in demand for multivalent vaccines.

The market for multivalent vaccines is anticipated to experience solid expansion in the approaching years. The market is projected to reach $13.05 billion by 2029, with a compound annual growth rate (CAGR) of 9.4%. The anticipated surge during this forecast period is due to an upswing in infectious diseases, an increment in the elderly population, augmented investment by both government and private sectors, heightened attention towards vaccine safety and efficiency, and an increasing focus on therapeutic vaccines. Key trends for the forecast period encompass a higher focus on combination vaccines, incorporation of digital health technologies, advancements in mRNA technology, the evolution of personalized vaccines, and an escalation in research activities.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19120&type=smp

What Underlying Factors Are Supporting The Multivalent Vaccines Market Growth?

The multivalent vaccines market is projected to see significant growth in light of escalating instances of infectious diseases. Such diseases are triggered by pathogens including bacteria, viruses, fungi, or parasites, characterised by their ability to transit through direct contact or via contaminated air, water, or surfaces, with severity spanning from mild to severe. The increasing prevalence of global travel makes it easy for these pathogens to cross borders, thus broadening the infection rate. Multivalent vaccines come equipped with the capacity to mitigate the spread of such diseases by offering protection against various strains of a single pathogen within one dosage, eliminating the requirement of several inoculations. This translates into a higher degree of herd immunity and a downward trend in disease prevalence, thus contributing to public health amelioration. Evidence of this was noted in a report by TravelHealthPro – a UK Health Security Agency-backed website, which recorded 2,004 malaria cases in the UK in April 2024, a significant rise from the 1,369 imported cases logged in 2022. Consequently, the increasing infectious disease occurrences are catalysing the expansion of the multivalent vaccines market.

How Is The Multivalent Vaccines Market Categorized Across Applications And Types?

The multivalent vaccines market covered in this report is segmented –

1) By Type: Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines

2) By Disease: Influenza, Pneumonia, Hepatitis, Meningitis, Rotavirus

3) By Route Of Administration: Oral, Injectable

4) By Age Group: Pediatrics, Adults, Geriatrics

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines, Protein Conjugate Vaccines

2) By Inactivated And Subunit Vaccines: Inactivated Whole Virus Vaccines, Subunit Protein Vaccines, Virus-Like Particle Vaccines

3) By Live Attenuated Vaccines: Live Attenuated Bacterial Vaccines, Live Attenuated Viral Vaccines

4) By Toxoid Vaccines: Diphtheria Toxoid Vaccines, Tetanus Toxoid Vaccines

5) By Recombinant Vaccines: Recombinant Protein Vaccines, Recombinant DNA Vaccines

How Are Market Trends Influencing Competition In The Multivalent Vaccines Market?

Leading corporations in the multivalent vaccines market are now focusing on creating progressive pentavalent vaccines, aiming to enhance public health by providing better protection against various diseases with a single dosage. A pentavalent vaccine is engineered to offer immunity from five different pathogens or varieties. The convenience of having these five protections encapsulated in a single vaccine enhances the overall vaccination rate and simplifies the immunization plan. For example, Panacea Biotec Ltd., a biotechnology firm based in India, released EasyFourPol in December 2023. This groundbreaking product is the world’s first fully liquid vaccine and shields against five grave illnesses: diphtheria, tetanus, pertussis, polio, and invasive infections caused by Haemophilus influenzae Type B. This ready-to-deliver blend vaccination eliminates the prerequisites of vaccine preparation by health professionals, thereby making the vaccination procedure more efficient. It provides comparable protection like single-antigen vaccines, diminishes the frequency of pediatric clinic visits, and also curtails the overall cost of immunization. Moreover, its positive contribution towards environmental sustainability is also noteworthy, as it reduces the necessity for vials, syringes, and packaging, thus minimizing the environmental footprint.

Who Are The Global Leaders Steering The Multivalent Vaccines Market Forward?

Major companies operating in the multivalent vaccines market are Pfizer Inc., Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Moderna Inc., BioNTech SE, Zydus Lifesciences Limited, CSL Seqirus, Sinovac Biotech Ltd., GC Biopharma corp., Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Indian Immunologicals Ltd., Bavarian Nordic, Panacea Biotec Ltd., WestVac Biopharma Co. Ltd., VBI Vaccines Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/multivalent-vaccines-global-market-report

What Are The Emerging Regional Trends Driving The Multivalent Vaccines Market?

North America was the largest region in the multivalent vaccines market in 2024. The regions covered in the multivalent vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=19120&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model